Posts

Showing posts from July, 2020

Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra - BioSpace

Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra    BioSpace

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis - GlobeNewswire

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis    GlobeNewswire

Emergency use of Cuban medicine against COVID-19 approved - OnCubaNews

Emergency use of Cuban medicine against COVID-19 approved    OnCubaNews

Rheumatology therapeutics Market Insights, Trends, Analysis, Types, Applications, key players, Market shares and Forecast 2019 to 2023 – Bulletin Line - Bulletin Line

Rheumatology therapeutics Market Insights, Trends, Analysis, Types, Applications, key players, Market shares and Forecast 2019 to 2023 – Bulletin Line    Bulletin Line

Coronavirus | U.S. President Donald Trump defends use of hydroxychloroquine, says it works in early stages of COVID-19 infection - The Hindu

Coronavirus | U.S. President Donald Trump defends use of hydroxychloroquine, says it works in early stages of COVID-19 infection    The Hindu

RA Therapy Studied for COVID-19 Does Not Meet Endpoint - Contagionlive.com

RA Therapy Studied for COVID-19 Does Not Meet Endpoint    Contagionlive.com

Dr. Fauci says all the 'valid' scientific data shows hydroxychloroquine isn't effective in treating coronavirus - CNBC

Dr. Fauci says all the 'valid' scientific data shows hydroxychloroquine isn't effective in treating coronavirus    CNBC

BioWorld MedTech's Orthopedics Extra for July 29, 2020 | 2020-07-29 | BioWorld - BioWorld Online

BioWorld MedTech's Orthopedics Extra for July 29, 2020 | 2020-07-29 | BioWorld    BioWorld Online

Hydroxychloroquine returns as wedge between President Trump, health advisers - ABC News

Hydroxychloroquine returns as wedge between President Trump, health advisers    ABC News

Top 5 Benefits of Taking Collagen Products | INQUIRER.net USA - INQUIRER.net

Top 5 Benefits of Taking Collagen Products | INQUIRER.net USA    INQUIRER.net

Getting Enough Nitric Oxide Can Prevent Aging and Disease - The Beet

Getting Enough Nitric Oxide Can Prevent Aging and Disease    The Beet

How to Spot Juvenile Arthritis in Your Child - Integris

How to Spot Juvenile Arthritis in Your Child    Integris

Hydroxychloroquine is trending again. It's still no cure for COVID-19 - CNET

Hydroxychloroquine is trending again. It's still no cure for COVID-19    CNET

Case Study Finds Arthritis Drug Could Make Gluten Safe For Celiac Patients - IFLScience

Case Study Finds Arthritis Drug Could Make Gluten Safe For Celiac Patients    IFLScience

Third Pivotal Phase 3 Study Shows RINVOQ™ (upadacitinib) Plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis Patients | Small Molecules | News Channels - PipelineReview.com

Third Pivotal Phase 3 Study Shows RINVOQ™ (upadacitinib) Plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis Patients | Small Molecules | News Channels    PipelineReview.com

Trump Shares Conspiracy Theory About Hydroxychloroquine and 2020 Election - Newsweek

Trump Shares Conspiracy Theory About Hydroxychloroquine and 2020 Election    Newsweek

IVX Health Opens Two New Infusion Centers in Orlando Area to Serve Patients with Complex Chronic Conditions - PRNewswire

IVX Health Opens Two New Infusion Centers in Orlando Area to Serve Patients with Complex Chronic Conditions    PRNewswire

CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment - BioSpace

CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment    BioSpace

Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra - BioSpace

Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra    BioSpace

What to Do About Side Effects From Steroids When You Have RA - HealthCentral.com

What to Do About Side Effects From Steroids When You Have RA    HealthCentral.com

RINVOQ™ (upadacitinib) Monotherapy Meets All Primary and Secondary Endpoints in Second Phase 3 Study for Atopic Dermatitis | Small Molecules | News Channels - PipelineReview.com

RINVOQ™ (upadacitinib) Monotherapy Meets All Primary and Secondary Endpoints in Second Phase 3 Study for Atopic Dermatitis | Small Molecules | News Channels    PipelineReview.com

Global Rheumatology Therapeutics Market 2020 Size, Growth Rate, Restraints, Driving Forcast 2025 - Market Research Posts

Global Rheumatology Therapeutics Market 2020 Size, Growth Rate, Restraints, Driving Forcast 2025    Market Research Posts

Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change - Yahoo Finance UK

Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change    Yahoo Finance UK

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows - News-Medical.Net

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows    News-Medical.Net

RINVOQ™ (upadacitinib) Monotherapy Meets All Primary and Secondary Endpoints in Second Phase 3 Study for Atopic Dermatitis | Small Molecules | News Channels - PipelineReview.com

RINVOQ™ (upadacitinib) Monotherapy Meets All Primary and Secondary Endpoints in Second Phase 3 Study for Atopic Dermatitis | Small Molecules | News Channels    PipelineReview.com

Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib - DocWire News

Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib    DocWire News

Rheumatoid Arthritis Drug May Fight Severe COVID-19, Early Data Show - U.S. News & World Report

Rheumatoid Arthritis Drug May Fight Severe COVID-19, Early Data Show    U.S. News & World Report

Heart Disease Often Missed in Rheumatoid Arthritis - Everyday Health

Heart Disease Often Missed in Rheumatoid Arthritis    Everyday Health

Tiziana Life Sciences plc ("Tiziana" or the "Company") Director Appointment - BioSpace

Tiziana Life Sciences plc ("Tiziana" or the "Company") Director Appointment    BioSpace

These cells spike before rheumatoid arthritis flare-ups - Futurity: Research News

These cells spike before rheumatoid arthritis flare-ups    Futurity: Research News

Heart Disease Often Missed in Rheumatoid Arthritis - Everyday Health

Heart Disease Often Missed in Rheumatoid Arthritis    Everyday Health

Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up study - DocWire News

Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up study    DocWire News

Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up study - DocWire News

Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up study    DocWire News

Results of Annual General Meeting | 2020-07-16 | Press Releases - Stockhouse

Results of Annual General Meeting | 2020-07-16 | Press Releases    Stockhouse

Biologics Development and Manufacturing Testing Market 2020 Global Trends, Industry Analysis by Size, Share, Segment, Regional Analysis, Growth Statistics Forecast to 2024 - Jewish Life News

Biologics Development and Manufacturing Testing Market 2020 Global Trends, Industry Analysis by Size, Share, Segment, Regional Analysis, Growth Statistics Forecast to 2024    Jewish Life News

How uji nutrients boost your health - The Star, Kenya

How uji nutrients boost your health    The Star, Kenya

Itolizumab is a breakthrough drug; Its Phase-IV trail will be conducted soon: Kiran Mazumdar Shaw, Biocon - Zee Business

Itolizumab is a breakthrough drug; Its Phase-IV trail will be conducted soon: Kiran Mazumdar Shaw, Biocon    Zee Business

Autoimmune Disease Treatment Market 2020 Analysis By Treatment Studies, Observational Studies With Key Competitors Abbott Laboratories, Amgen - Cole of Duty

Autoimmune Disease Treatment Market 2020 Analysis By Treatment Studies, Observational Studies With Key Competitors Abbott Laboratories, Amgen    Cole of Duty

Blood test could reveal timing of rheumatoid arthritis flare-up – study - The Irish News

Blood test could reveal timing of rheumatoid arthritis flare-up – study    The Irish News

Cel-Sci Corporation - Consensus Indicates Potential 58.2% Upside - DirectorsTalk Interviews

Cel-Sci Corporation - Consensus Indicates Potential 58.2% Upside    DirectorsTalk Interviews

Global Region Likely to Dominate the Antinuclear Antibody Test Market Over the Forecast Period 2019-2029 - Jewish Life News

Global Region Likely to Dominate the Antinuclear Antibody Test Market Over the Forecast Period 2019-2029    Jewish Life News

Cel-Sci Corporation - Consensus Indicates Potential 58.2% Upside - DirectorsTalk Interviews

Cel-Sci Corporation - Consensus Indicates Potential 58.2% Upside    DirectorsTalk Interviews

Global Region Likely to Dominate the Antinuclear Antibody Test Market Over the Forecast Period 2019-2029 - Jewish Life News

Global Region Likely to Dominate the Antinuclear Antibody Test Market Over the Forecast Period 2019-2029    Jewish Life News

Treatment with methotrexate and risk of lung disease in patients with rheumatoid arthritis - Medical Xpress

Treatment with methotrexate and risk of lung disease in patients with rheumatoid arthritis    Medical Xpress

Rheumatoid Arthritis Treatment Market Outlook Analysis by 2029 - Jewish Life News

Rheumatoid Arthritis Treatment Market Outlook Analysis by 2029    Jewish Life News

Researchers develop new approach to study the genetics of human disease - Medical Xpress

Researchers develop new approach to study the genetics of human disease    Medical Xpress

These scientists raced to find a COVID-19 drug. Then the virus found them. - Baltimore Sun

These scientists raced to find a COVID-19 drug. Then the virus found them.    Baltimore Sun

Mylan (MYL) and Fujifilm Kyowa Kirin Biologics Announce US FDA Approval of Hulio - StreetInsider.com

Mylan (MYL) and Fujifilm Kyowa Kirin Biologics Announce US FDA Approval of Hulio    StreetInsider.com

What is the best way to treat COVID-19? Remdesivir and plasma are promising, but other drugs are needed. - NBC News

What is the best way to treat COVID-19? Remdesivir and plasma are promising, but other drugs are needed.    NBC News

Q&A: Chronic Chikungunya Arthritis vs. Rheumatoid Arthritis - Rheumatology Network

Q&A: Chronic Chikungunya Arthritis vs. Rheumatoid Arthritis    Rheumatology Network

Sjogren's Syndrome Epidemiology Forecast, Diagnosis, Treatment Options by DelveInsight - Jewish Life News

Sjogren's Syndrome Epidemiology Forecast, Diagnosis, Treatment Options by DelveInsight    Jewish Life News

Challenge Testing | In the Pipeline - Science Magazine

Challenge Testing | In the Pipeline    Science Magazine

Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data - The BMJ

Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data    The BMJ

Lessons from a network meta-analysis of biologics in rheumatoid arthritis - The BMJ - The BMJ

Lessons from a network meta-analysis of biologics in rheumatoid arthritis - The BMJ    The BMJ

Skeletal Muscle Disease and Cardiometabolic Dysfunction in Rheumatoid Arthritis - Rheumatology Advisor

Skeletal Muscle Disease and Cardiometabolic Dysfunction in Rheumatoid Arthritis    Rheumatology Advisor

A key gene modifies regulatory T cells to fine-tune the immune response - EurekAlert

A key gene modifies regulatory T cells to fine-tune the immune response    EurekAlert

Cyxone Signs Agreement With Dr Maarten Kraan as Senior Scientific Advisor - Stockhouse

Cyxone Signs Agreement With Dr Maarten Kraan as Senior Scientific Advisor    Stockhouse

Hydroxychloroquine, azithromycin prescriptions skyrocket amid early days of COVID-19 - Healio

Hydroxychloroquine, azithromycin prescriptions skyrocket amid early days of COVID-19    Healio

Remsima as Home Injection Favored to Treat Ankylosing Spondylitis in EU - Ankylosing Spondylitis News

Remsima as Home Injection Favored to Treat Ankylosing Spondylitis in EU    Ankylosing Spondylitis News

Remsima as Home Injection Favored to Treat Ankylosing Spondylitis in EU - Ankylosing Spondylitis News

Remsima as Home Injection Favored to Treat Ankylosing Spondylitis in EU    Ankylosing Spondylitis News

When Licensing New Tech Is Better Than Building It In-House - Harvard Business Review

When Licensing New Tech Is Better Than Building It In-House    Harvard Business Review

Arthritis: Eating more of this vegetable will help reduce pain felt in the joints - Express

Arthritis: Eating more of this vegetable will help reduce pain felt in the joints    Express

Arthritis pain - the best oil to use while cooking your dinner to lower your risk of signs - Express

Arthritis pain - the best oil to use while cooking your dinner to lower your risk of signs    Express

The 80/20 Rule And Low-Impact Exercise Helped Me Lose 60 Pounds - Women's Health

The 80/20 Rule And Low-Impact Exercise Helped Me Lose 60 Pounds    Women's Health

Why your joints hurt in winter – and what you can do to keep them healthy - Health24

Why your joints hurt in winter – and what you can do to keep them healthy    Health24

Reactive Arthritis - Harvard Health

Reactive Arthritis    Harvard Health

Shares of Gilead Have Cooled Off: Is Now the Time to Buy? - The Motley Fool

Shares of Gilead Have Cooled Off: Is Now the Time to Buy?    The Motley Fool

When Licensing New Tech Is Better Than Building It In-House - Harvard Business Review

When Licensing New Tech Is Better Than Building It In-House    Harvard Business Review

Smart structures: Structural cells of the body control immune function - Science Daily

Smart structures: Structural cells of the body control immune function    Science Daily

Rheumatology Group Issues Position Paper Supporting Telehealth Use - mHealthIntelligence.com

Rheumatology Group Issues Position Paper Supporting Telehealth Use    mHealthIntelligence.com

Local hospitals using recommended, investigative treatment methods to care for patients with COVID-19 - KoamNewsNow.com

Local hospitals using recommended, investigative treatment methods to care for patients with COVID-19    KoamNewsNow.com

Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 US Trial in COVID-19 Patients - PRNewswire

Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 US Trial in COVID-19 Patients    PRNewswire

What Other Conditions Can You Have With Fibromyalgia? - Yahoo! Voices

What Other Conditions Can You Have With Fibromyalgia?    Yahoo! Voices

Medical herbalist Nicola Parker explains the treatment for different types of arthritis - Burnley Express

Medical herbalist Nicola Parker explains the treatment for different types of arthritis    Burnley Express

Halle Berry Cut These 3 Things Out Of Her Diet Years Ago And Hasn't Looked Back Since - Yahoo Lifestyle

Halle Berry Cut These 3 Things Out Of Her Diet Years Ago And Hasn't Looked Back Since    Yahoo Lifestyle

Scientists at La Jolla Institute for Immunology investigate powerful protein behind antibody development - La Jolla Light

Scientists at La Jolla Institute for Immunology investigate powerful protein behind antibody development    La Jolla Light

Medical herbalist Nicola Parker explains the treatment for different types of arthritis - Burnley Express

Medical herbalist Nicola Parker explains the treatment for different types of arthritis    Burnley Express

Better Buy: Vertex Pharmaceuticals vs. Galapagos - Nasdaq

Better Buy: Vertex Pharmaceuticals vs. Galapagos    Nasdaq

Smart structures: Structural cells of the body control immune function - Science Daily

Smart structures: Structural cells of the body control immune function    Science Daily

Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 US Trial in COVID-19 Patients - BioSpace

Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 US Trial in COVID-19 Patients    BioSpace

Smart structures: Structural cells of the body control immune function - Science Daily

Smart structures: Structural cells of the body control immune function    Science Daily

Hydroxychloroquine Given Early Helped Coronavirus Patients, Study Finds - The Wall Street Journal

Hydroxychloroquine Given Early Helped Coronavirus Patients, Study Finds    The Wall Street Journal

How doctors are innovating to treat COVID-19 - PBS NewsHour

How doctors are innovating to treat COVID-19    PBS NewsHour

Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise - Yahoo Finance

Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise    Yahoo Finance

Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal - Science Advances

Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal    Science Advances

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study - The Lancet

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study    The Lancet